Effects of patient age on patency of chronic hemodialysis vascular access

Seonjeong Jeong1, Hyunwook Kwon1, Jai Won Chang2

  • 1Division of Vascular Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.

BMC Nephrology
|November 23, 2019
PubMed

Insights

Older hemodialysis patients benefit from arteriovenous fistula (AVF) placement, showing longer primary and secondary patency. A fistula-first approach is recommended for appropriate elderly patients to improve vascular access longevity.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Public Health

Background:

  • Assessing long-term vascular access (VA) patency in hemodialysis (HD) patients.
  • Identifying independent risk factors for VA patency in Asian HD patients, stratified by age.
  • Investigating VA patency factors in older HD patients based on access type.

Purpose of the Study:

  • To evaluate the long-term patency of vascular access (VA) after initial placement in hemodialysis (HD) patients.
  • To identify independent risk factors for VA patency in Asian HD patients, considering age stratification.
  • To examine factors influencing VA patency in elderly HD patients based on the type of VA used.

Main Methods:

  • Retrospective observational study of 651 chronic HD patients with first upper-extremity VA placement (Jan 2011-Dec 2013).
  • Patients stratified into nonelderly (<65 years) and elderly (≥65 years) groups.
  • Kaplan-Meier survival analysis and multivariate analysis to determine primary and secondary VA patency outcomes.

Main Results:

  • Autologous arteriovenous fistula (AVF) was more frequent in nonelderly patients.
  • Primary patency was longer in nonelderly patients; secondary patency was similar between age groups.
  • Increased age correlated with shorter primary patency; AVF placement was associated with longer primary and secondary patency. Diabetes mellitus was linked to shorter secondary patency.

Conclusions:

  • Increased age negatively impacts primary VA patency but not secondary patency.
  • Arteriovenous fistula (AVF) placement is associated with superior primary and secondary patency compared to other VA types.
  • A fistula-first strategy is recommended for suitable elderly hemodialysis patients to enhance vascular access outcomes.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
651
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
207
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
532
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
182
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
158